Joint Position Statement from the National Psoriasis Foundation Medical Board and the International Psoriasis Council on Routine Testing for Latent Tuberculosis Infection Prior To and During Treatment of Psoriasis Patients with IL-17 or IL-23 Inhibitors
Related Posts
Freeman M, Gates G, Ahronowitz I. Merkel Cell Carcinoma Masquerading as Dermatitis. Cureus. 2026 Sep 19;18(9):e116561. doi: 10.7759/cureus.116561. PMID: 42903405; PMCID: PMC13680730.
Ethical Implications of Patient-Requested Cessation of Mohs Micrographic Surgery with Residual Tumor
Ajmani A, Sanjeev R, Klufas T, Zhou AE, Davis JC, Grant-Kels JM. Ethical Implications of Patient-Requested Cessation of Mohs Micrographic Surgery with Residual Tumor. J[...]
McInnes IB, Stein Gold L, Bissonnette R, Lebwohl MG, Reyes-Servin O, Cafone J, Yang YW, Chakravarty SD, Iaconangelo C, Li S, Shagroni T, Lozenski K,[...]